CLOV vs PTHS · rev $1.37B vs rev $7.4M
Clover Health Investments Corp (CLOV) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PTHS revenue for 2025-09-30 was $7.4M. Net income was -$16.2M. PTHS currently screens at market cap $94.7M.
CLOV currently screens at market cap $1.55B. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the CLOV and PTHS stock pages for the full models.
Not investment advice.